Arterial enhancement fraction in evaluating the therapeutic effect and survival for hepatocellular carcinoma patients treated with deb-tace

HIGHLIGHTS

  • who: Bin Chai from the Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science Technology, Wuhan, China have published the research: Arterial enhancement fraction in evaluating the therapeutic effect and survival for hepatocellular carcinoma patients treated with DEB-TACE, in the Journal: (JOURNAL) of September/30,/2021
  • what: The aim of this study was to retrospectively investigate the relationship between AEF treatment response survival in hepatocellular carcinoma (HCC) patients treated with drug-eluting bead (DEB) TACE. The study assessed the changes in AEF of HCC after DEB-TACE and investigated the relationships . . .

     

    Logo ScioWire Beta black

    If you want to have access to all the content you need to log in!

    Thanks :)

    If you don't have an account, you can create one here.

     

Scroll to Top

Add A Knowledge Base Question !

+ = Verify Human or Spambot ?